if DMN has nothing from results, they still have other projects, if all fails they are only $11 mill m/c and that is pretty much shell priced, forget about the number of options, if options are exercised that will mean they have found something
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025